nodes	percent_of_prediction	percent_of_DWPC	metapath
Niacin—Metyrapone—CYP2E1—liver cancer	0.00873	0.844	CrCbGaD
Niacin—Necrosis—Epirubicin—liver cancer	0.00219	0.00454	CcSEcCtD
Niacin—Tinnitus—Sorafenib—liver cancer	0.00218	0.00451	CcSEcCtD
Niacin—Flushing—Sorafenib—liver cancer	0.00217	0.00449	CcSEcCtD
Niacin—Rash pustular—Epirubicin—liver cancer	0.00215	0.00447	CcSEcCtD
Niacin—Haemoptysis—Doxorubicin—liver cancer	0.00215	0.00445	CcSEcCtD
Niacin—Angiopathy—Sorafenib—liver cancer	0.00212	0.00439	CcSEcCtD
Niacin—Herpes zoster—Doxorubicin—liver cancer	0.00211	0.00438	CcSEcCtD
Niacin—Arrhythmia—Sorafenib—liver cancer	0.00209	0.00433	CcSEcCtD
Niacin—Alopecia—Sorafenib—liver cancer	0.00206	0.00428	CcSEcCtD
Niacin—Amblyopia—Doxorubicin—liver cancer	0.00206	0.00427	CcSEcCtD
Niacin—Skin ulcer—Doxorubicin—liver cancer	0.00204	0.00423	CcSEcCtD
Niacin—Malnutrition—Sorafenib—liver cancer	0.00203	0.00421	CcSEcCtD
Niacin—Erythema—Sorafenib—liver cancer	0.00203	0.00421	CcSEcCtD
Niacin—Feeling hot—Doxorubicin—liver cancer	0.00203	0.0042	CcSEcCtD
Niacin—Necrosis—Doxorubicin—liver cancer	0.00203	0.0042	CcSEcCtD
Niacin—Rash pustular—Doxorubicin—liver cancer	0.00199	0.00413	CcSEcCtD
Niacin—Breast pain—Epirubicin—liver cancer	0.00197	0.00408	CcSEcCtD
Niacin—Jaundice cholestatic—Epirubicin—liver cancer	0.00196	0.00406	CcSEcCtD
Niacin—Muscle spasms—Sorafenib—liver cancer	0.00195	0.00405	CcSEcCtD
Niacin—Skin discolouration—Epirubicin—liver cancer	0.0019	0.00394	CcSEcCtD
Niacin—Bone disorder—Epirubicin—liver cancer	0.0019	0.00394	CcSEcCtD
Niacin—Hyperbilirubinaemia—Epirubicin—liver cancer	0.00189	0.00392	CcSEcCtD
Niacin—Cough increased—Epirubicin—liver cancer	0.00188	0.00389	CcSEcCtD
Niacin—Angioedema—Sorafenib—liver cancer	0.00186	0.00385	CcSEcCtD
Niacin—Hyperuricaemia—Epirubicin—liver cancer	0.00185	0.00384	CcSEcCtD
Niacin—Syncope—Sorafenib—liver cancer	0.00182	0.00378	CcSEcCtD
Niacin—Breast pain—Doxorubicin—liver cancer	0.00182	0.00378	CcSEcCtD
Niacin—Leukopenia—Sorafenib—liver cancer	0.00182	0.00377	CcSEcCtD
Niacin—Jaundice cholestatic—Doxorubicin—liver cancer	0.00181	0.00375	CcSEcCtD
Niacin—Loss of consciousness—Sorafenib—liver cancer	0.00179	0.0037	CcSEcCtD
Niacin—Cough—Sorafenib—liver cancer	0.00177	0.00368	CcSEcCtD
Niacin—Skin discolouration—Doxorubicin—liver cancer	0.00176	0.00365	CcSEcCtD
Niacin—Bone disorder—Doxorubicin—liver cancer	0.00176	0.00365	CcSEcCtD
Niacin—Blood uric acid increased—Epirubicin—liver cancer	0.00175	0.00363	CcSEcCtD
Niacin—Hyperbilirubinaemia—Doxorubicin—liver cancer	0.00175	0.00363	CcSEcCtD
Niacin—Cough increased—Doxorubicin—liver cancer	0.00174	0.0036	CcSEcCtD
Niacin—Arthralgia—Sorafenib—liver cancer	0.00173	0.00359	CcSEcCtD
Niacin—Myalgia—Sorafenib—liver cancer	0.00173	0.00359	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00172	0.00356	CcSEcCtD
Niacin—Vaginal inflammation—Epirubicin—liver cancer	0.00172	0.00356	CcSEcCtD
Niacin—Hyperuricaemia—Doxorubicin—liver cancer	0.00171	0.00355	CcSEcCtD
Niacin—Dermatitis contact—Epirubicin—liver cancer	0.0017	0.00352	CcSEcCtD
Niacin—Dry mouth—Sorafenib—liver cancer	0.00169	0.00351	CcSEcCtD
Niacin—Eructation—Epirubicin—liver cancer	0.00169	0.0035	CcSEcCtD
Niacin—Anaphylactic shock—Sorafenib—liver cancer	0.00166	0.00344	CcSEcCtD
Niacin—Skin exfoliation—Epirubicin—liver cancer	0.00164	0.0034	CcSEcCtD
Niacin—Shock—Sorafenib—liver cancer	0.00163	0.00338	CcSEcCtD
Niacin—Fluid retention—Epirubicin—liver cancer	0.00163	0.00338	CcSEcCtD
Niacin—Vaginal infection—Epirubicin—liver cancer	0.00162	0.00336	CcSEcCtD
Niacin—Blood uric acid increased—Doxorubicin—liver cancer	0.00162	0.00336	CcSEcCtD
Niacin—Salicylic acid—ALB—liver cancer	0.00162	0.156	CrCbGaD
Niacin—Skin disorder—Sorafenib—liver cancer	0.00161	0.00334	CcSEcCtD
Niacin—Vaginal inflammation—Doxorubicin—liver cancer	0.00159	0.0033	CcSEcCtD
Niacin—Anorexia—Sorafenib—liver cancer	0.00158	0.00328	CcSEcCtD
Niacin—Cramps of lower extremities—Epirubicin—liver cancer	0.00158	0.00327	CcSEcCtD
Niacin—Dermatitis contact—Doxorubicin—liver cancer	0.00157	0.00326	CcSEcCtD
Niacin—Oesophagitis—Epirubicin—liver cancer	0.00157	0.00326	CcSEcCtD
Niacin—Eructation—Doxorubicin—liver cancer	0.00156	0.00324	CcSEcCtD
Niacin—Rash maculo-papular—Epirubicin—liver cancer	0.00156	0.00324	CcSEcCtD
Niacin—Skin exfoliation—Doxorubicin—liver cancer	0.00152	0.00315	CcSEcCtD
Niacin—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00151	0.00313	CcSEcCtD
Niacin—Fluid retention—Doxorubicin—liver cancer	0.00151	0.00313	CcSEcCtD
Niacin—Hypertonia—Epirubicin—liver cancer	0.00151	0.00312	CcSEcCtD
Niacin—Vaginal infection—Doxorubicin—liver cancer	0.0015	0.00311	CcSEcCtD
Niacin—Abnormal vision—Epirubicin—liver cancer	0.0015	0.00311	CcSEcCtD
Niacin—Dyspnoea—Sorafenib—liver cancer	0.00148	0.00307	CcSEcCtD
Niacin—Cramps of lower extremities—Doxorubicin—liver cancer	0.00146	0.00303	CcSEcCtD
Niacin—Dyspepsia—Sorafenib—liver cancer	0.00146	0.00303	CcSEcCtD
Niacin—Oesophagitis—Doxorubicin—liver cancer	0.00145	0.00301	CcSEcCtD
Niacin—Rash maculo-papular—Doxorubicin—liver cancer	0.00145	0.003	CcSEcCtD
Niacin—Decreased appetite—Sorafenib—liver cancer	0.00144	0.00299	CcSEcCtD
Niacin—Diabetes mellitus—Epirubicin—liver cancer	0.00143	0.00297	CcSEcCtD
Niacin—Gastrointestinal disorder—Sorafenib—liver cancer	0.00143	0.00297	CcSEcCtD
Niacin—Hepatic function abnormal—Epirubicin—liver cancer	0.00143	0.00296	CcSEcCtD
Niacin—Pain—Sorafenib—liver cancer	0.00142	0.00294	CcSEcCtD
Niacin—Hypertonia—Doxorubicin—liver cancer	0.00139	0.00289	CcSEcCtD
Niacin—Eczema—Epirubicin—liver cancer	0.00139	0.00288	CcSEcCtD
Niacin—Abnormal vision—Doxorubicin—liver cancer	0.00139	0.00288	CcSEcCtD
Niacin—Gastrointestinal pain—Sorafenib—liver cancer	0.00136	0.00281	CcSEcCtD
Niacin—Diabetes mellitus—Doxorubicin—liver cancer	0.00133	0.00275	CcSEcCtD
Niacin—Hepatic function abnormal—Doxorubicin—liver cancer	0.00132	0.00274	CcSEcCtD
Niacin—Urticaria—Sorafenib—liver cancer	0.00132	0.00273	CcSEcCtD
Niacin—Abdominal pain—Sorafenib—liver cancer	0.00131	0.00272	CcSEcCtD
Niacin—Body temperature increased—Sorafenib—liver cancer	0.00131	0.00272	CcSEcCtD
Niacin—Dermatitis bullous—Epirubicin—liver cancer	0.00131	0.00271	CcSEcCtD
Niacin—Eczema—Doxorubicin—liver cancer	0.00128	0.00266	CcSEcCtD
Niacin—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.00125	0.00259	CcSEcCtD
Niacin—Migraine—Epirubicin—liver cancer	0.00123	0.00255	CcSEcCtD
Niacin—Hypersensitivity—Sorafenib—liver cancer	0.00122	0.00253	CcSEcCtD
Niacin—Dermatitis bullous—Doxorubicin—liver cancer	0.00121	0.0025	CcSEcCtD
Niacin—Face oedema—Epirubicin—liver cancer	0.0012	0.0025	CcSEcCtD
Niacin—Asthenia—Sorafenib—liver cancer	0.00119	0.00247	CcSEcCtD
Niacin—Pruritus—Sorafenib—liver cancer	0.00117	0.00243	CcSEcCtD
Niacin—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.00115	0.00239	CcSEcCtD
Niacin—Liver function test abnormal—Epirubicin—liver cancer	0.00115	0.00239	CcSEcCtD
Niacin—Dry skin—Epirubicin—liver cancer	0.00114	0.00237	CcSEcCtD
Niacin—Orthostatic hypotension—Epirubicin—liver cancer	0.00114	0.00236	CcSEcCtD
Niacin—Migraine—Doxorubicin—liver cancer	0.00114	0.00236	CcSEcCtD
Niacin—Diarrhoea—Sorafenib—liver cancer	0.00114	0.00235	CcSEcCtD
Niacin—Face oedema—Doxorubicin—liver cancer	0.00111	0.00231	CcSEcCtD
Niacin—Muscular weakness—Epirubicin—liver cancer	0.0011	0.00228	CcSEcCtD
Niacin—Dizziness—Sorafenib—liver cancer	0.0011	0.00227	CcSEcCtD
Niacin—Abdominal distension—Epirubicin—liver cancer	0.00109	0.00225	CcSEcCtD
Niacin—Dysphagia—Epirubicin—liver cancer	0.00108	0.00224	CcSEcCtD
Niacin—Influenza—Epirubicin—liver cancer	0.00108	0.00224	CcSEcCtD
Niacin—Liver function test abnormal—Doxorubicin—liver cancer	0.00107	0.00221	CcSEcCtD
Niacin—Dry skin—Doxorubicin—liver cancer	0.00106	0.00219	CcSEcCtD
Niacin—Vomiting—Sorafenib—liver cancer	0.00105	0.00219	CcSEcCtD
Niacin—Orthostatic hypotension—Doxorubicin—liver cancer	0.00105	0.00219	CcSEcCtD
Niacin—Angina pectoris—Epirubicin—liver cancer	0.00105	0.00218	CcSEcCtD
Niacin—Rash—Sorafenib—liver cancer	0.00105	0.00217	CcSEcCtD
Niacin—Dermatitis—Sorafenib—liver cancer	0.00105	0.00217	CcSEcCtD
Niacin—Headache—Sorafenib—liver cancer	0.00104	0.00215	CcSEcCtD
Niacin—Bronchitis—Epirubicin—liver cancer	0.00104	0.00215	CcSEcCtD
Niacin—Muscular weakness—Doxorubicin—liver cancer	0.00102	0.00211	CcSEcCtD
Niacin—Abdominal distension—Doxorubicin—liver cancer	0.001	0.00208	CcSEcCtD
Niacin—Dysphagia—Doxorubicin—liver cancer	0.000998	0.00207	CcSEcCtD
Niacin—Influenza—Doxorubicin—liver cancer	0.000998	0.00207	CcSEcCtD
Niacin—Nausea—Sorafenib—liver cancer	0.000985	0.00204	CcSEcCtD
Niacin—Angina pectoris—Doxorubicin—liver cancer	0.000972	0.00201	CcSEcCtD
Niacin—Bronchitis—Doxorubicin—liver cancer	0.000959	0.00199	CcSEcCtD
Niacin—Jaundice—Epirubicin—liver cancer	0.000937	0.00194	CcSEcCtD
Niacin—Stomatitis—Epirubicin—liver cancer	0.000937	0.00194	CcSEcCtD
Niacin—Sweating—Epirubicin—liver cancer	0.000922	0.00191	CcSEcCtD
Niacin—Haemoglobin—Epirubicin—liver cancer	0.000867	0.0018	CcSEcCtD
Niacin—Stomatitis—Doxorubicin—liver cancer	0.000867	0.0018	CcSEcCtD
Niacin—Jaundice—Doxorubicin—liver cancer	0.000867	0.0018	CcSEcCtD
Niacin—Rhinitis—Epirubicin—liver cancer	0.000865	0.00179	CcSEcCtD
Niacin—Haemorrhage—Epirubicin—liver cancer	0.000863	0.00179	CcSEcCtD
Niacin—Hepatitis—Epirubicin—liver cancer	0.000863	0.00179	CcSEcCtD
Niacin—Hypoaesthesia—Epirubicin—liver cancer	0.000859	0.00178	CcSEcCtD
Niacin—Sweating—Doxorubicin—liver cancer	0.000853	0.00177	CcSEcCtD
Niacin—Oedema peripheral—Epirubicin—liver cancer	0.00085	0.00176	CcSEcCtD
Niacin—Visual impairment—Epirubicin—liver cancer	0.000832	0.00172	CcSEcCtD
Niacin—Eye disorder—Epirubicin—liver cancer	0.000806	0.00167	CcSEcCtD
Niacin—Tinnitus—Epirubicin—liver cancer	0.000805	0.00167	CcSEcCtD
Niacin—Haemoglobin—Doxorubicin—liver cancer	0.000803	0.00166	CcSEcCtD
Niacin—Flushing—Epirubicin—liver cancer	0.000801	0.00166	CcSEcCtD
Niacin—Rhinitis—Doxorubicin—liver cancer	0.000801	0.00166	CcSEcCtD
Niacin—Haemorrhage—Doxorubicin—liver cancer	0.000799	0.00166	CcSEcCtD
Niacin—Hepatitis—Doxorubicin—liver cancer	0.000799	0.00166	CcSEcCtD
Niacin—Hypoaesthesia—Doxorubicin—liver cancer	0.000795	0.00165	CcSEcCtD
Niacin—Oedema peripheral—Doxorubicin—liver cancer	0.000787	0.00163	CcSEcCtD
Niacin—Angiopathy—Epirubicin—liver cancer	0.000783	0.00162	CcSEcCtD
Niacin—Chills—Epirubicin—liver cancer	0.000774	0.00161	CcSEcCtD
Niacin—Arrhythmia—Epirubicin—liver cancer	0.000771	0.0016	CcSEcCtD
Niacin—Visual impairment—Doxorubicin—liver cancer	0.00077	0.0016	CcSEcCtD
Niacin—Alopecia—Epirubicin—liver cancer	0.000763	0.00158	CcSEcCtD
Niacin—Erythema—Epirubicin—liver cancer	0.000751	0.00156	CcSEcCtD
Niacin—Malnutrition—Epirubicin—liver cancer	0.000751	0.00156	CcSEcCtD
Niacin—Eye disorder—Doxorubicin—liver cancer	0.000746	0.00155	CcSEcCtD
Niacin—Tinnitus—Doxorubicin—liver cancer	0.000745	0.00154	CcSEcCtD
Niacin—Flushing—Doxorubicin—liver cancer	0.000741	0.00154	CcSEcCtD
Niacin—Flatulence—Epirubicin—liver cancer	0.00074	0.00153	CcSEcCtD
Niacin—Tension—Epirubicin—liver cancer	0.000737	0.00153	CcSEcCtD
Niacin—Nervousness—Epirubicin—liver cancer	0.00073	0.00151	CcSEcCtD
Niacin—Angiopathy—Doxorubicin—liver cancer	0.000724	0.0015	CcSEcCtD
Niacin—Muscle spasms—Epirubicin—liver cancer	0.000722	0.0015	CcSEcCtD
Niacin—Chills—Doxorubicin—liver cancer	0.000716	0.00149	CcSEcCtD
Niacin—Arrhythmia—Doxorubicin—liver cancer	0.000713	0.00148	CcSEcCtD
Niacin—Vision blurred—Epirubicin—liver cancer	0.000708	0.00147	CcSEcCtD
Niacin—Alopecia—Doxorubicin—liver cancer	0.000706	0.00146	CcSEcCtD
Niacin—Malnutrition—Doxorubicin—liver cancer	0.000695	0.00144	CcSEcCtD
Niacin—Erythema—Doxorubicin—liver cancer	0.000695	0.00144	CcSEcCtD
Niacin—Flatulence—Doxorubicin—liver cancer	0.000685	0.00142	CcSEcCtD
Niacin—Tension—Doxorubicin—liver cancer	0.000682	0.00141	CcSEcCtD
Niacin—Nervousness—Doxorubicin—liver cancer	0.000675	0.0014	CcSEcCtD
Niacin—Vertigo—Epirubicin—liver cancer	0.000675	0.0014	CcSEcCtD
Niacin—Syncope—Epirubicin—liver cancer	0.000674	0.0014	CcSEcCtD
Niacin—Leukopenia—Epirubicin—liver cancer	0.000672	0.00139	CcSEcCtD
Niacin—Muscle spasms—Doxorubicin—liver cancer	0.000668	0.00139	CcSEcCtD
Niacin—Palpitations—Epirubicin—liver cancer	0.000664	0.00138	CcSEcCtD
Niacin—Loss of consciousness—Epirubicin—liver cancer	0.00066	0.00137	CcSEcCtD
Niacin—Cough—Epirubicin—liver cancer	0.000656	0.00136	CcSEcCtD
Niacin—Vision blurred—Doxorubicin—liver cancer	0.000655	0.00136	CcSEcCtD
Niacin—Arthralgia—Epirubicin—liver cancer	0.00064	0.00133	CcSEcCtD
Niacin—Myalgia—Epirubicin—liver cancer	0.00064	0.00133	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000635	0.00132	CcSEcCtD
Niacin—Dry mouth—Epirubicin—liver cancer	0.000626	0.0013	CcSEcCtD
Niacin—Vertigo—Doxorubicin—liver cancer	0.000625	0.00129	CcSEcCtD
Niacin—Syncope—Doxorubicin—liver cancer	0.000623	0.00129	CcSEcCtD
Niacin—Leukopenia—Doxorubicin—liver cancer	0.000622	0.00129	CcSEcCtD
Niacin—Palpitations—Doxorubicin—liver cancer	0.000614	0.00127	CcSEcCtD
Niacin—Anaphylactic shock—Epirubicin—liver cancer	0.000613	0.00127	CcSEcCtD
Niacin—Oedema—Epirubicin—liver cancer	0.000613	0.00127	CcSEcCtD
Niacin—Loss of consciousness—Doxorubicin—liver cancer	0.000611	0.00127	CcSEcCtD
Niacin—Cough—Doxorubicin—liver cancer	0.000607	0.00126	CcSEcCtD
Niacin—Shock—Epirubicin—liver cancer	0.000603	0.00125	CcSEcCtD
Niacin—Tachycardia—Epirubicin—liver cancer	0.000598	0.00124	CcSEcCtD
Niacin—Skin disorder—Epirubicin—liver cancer	0.000596	0.00123	CcSEcCtD
Niacin—Hyperhidrosis—Epirubicin—liver cancer	0.000593	0.00123	CcSEcCtD
Niacin—Arthralgia—Doxorubicin—liver cancer	0.000592	0.00123	CcSEcCtD
Niacin—Myalgia—Doxorubicin—liver cancer	0.000592	0.00123	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000588	0.00122	CcSEcCtD
Niacin—Anorexia—Epirubicin—liver cancer	0.000584	0.00121	CcSEcCtD
Niacin—Dry mouth—Doxorubicin—liver cancer	0.000579	0.0012	CcSEcCtD
Niacin—Hypotension—Epirubicin—liver cancer	0.000573	0.00119	CcSEcCtD
Niacin—Oedema—Doxorubicin—liver cancer	0.000567	0.00118	CcSEcCtD
Niacin—Anaphylactic shock—Doxorubicin—liver cancer	0.000567	0.00118	CcSEcCtD
Niacin—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000559	0.00116	CcSEcCtD
Niacin—Shock—Doxorubicin—liver cancer	0.000558	0.00116	CcSEcCtD
Niacin—Insomnia—Epirubicin—liver cancer	0.000555	0.00115	CcSEcCtD
Niacin—Tachycardia—Doxorubicin—liver cancer	0.000554	0.00115	CcSEcCtD
Niacin—Skin disorder—Doxorubicin—liver cancer	0.000551	0.00114	CcSEcCtD
Niacin—Paraesthesia—Epirubicin—liver cancer	0.000551	0.00114	CcSEcCtD
Niacin—Hyperhidrosis—Doxorubicin—liver cancer	0.000548	0.00114	CcSEcCtD
Niacin—Dyspnoea—Epirubicin—liver cancer	0.000547	0.00113	CcSEcCtD
Niacin—Somnolence—Epirubicin—liver cancer	0.000545	0.00113	CcSEcCtD
Niacin—Anorexia—Doxorubicin—liver cancer	0.000541	0.00112	CcSEcCtD
Niacin—Dyspepsia—Epirubicin—liver cancer	0.00054	0.00112	CcSEcCtD
Niacin—Decreased appetite—Epirubicin—liver cancer	0.000533	0.00111	CcSEcCtD
Niacin—Hypotension—Doxorubicin—liver cancer	0.00053	0.0011	CcSEcCtD
Niacin—Gastrointestinal disorder—Epirubicin—liver cancer	0.000529	0.0011	CcSEcCtD
Niacin—Pain—Epirubicin—liver cancer	0.000524	0.00109	CcSEcCtD
Niacin—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000517	0.00107	CcSEcCtD
Niacin—Insomnia—Doxorubicin—liver cancer	0.000513	0.00106	CcSEcCtD
Niacin—Paraesthesia—Doxorubicin—liver cancer	0.000509	0.00106	CcSEcCtD
Niacin—Dyspnoea—Doxorubicin—liver cancer	0.000506	0.00105	CcSEcCtD
Niacin—Somnolence—Doxorubicin—liver cancer	0.000504	0.00105	CcSEcCtD
Niacin—Gastrointestinal pain—Epirubicin—liver cancer	0.000501	0.00104	CcSEcCtD
Niacin—Dyspepsia—Doxorubicin—liver cancer	0.000499	0.00104	CcSEcCtD
Niacin—Decreased appetite—Doxorubicin—liver cancer	0.000493	0.00102	CcSEcCtD
Niacin—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00049	0.00102	CcSEcCtD
Niacin—Urticaria—Epirubicin—liver cancer	0.000487	0.00101	CcSEcCtD
Niacin—Pain—Doxorubicin—liver cancer	0.000485	0.00101	CcSEcCtD
Niacin—Body temperature increased—Epirubicin—liver cancer	0.000485	0.001	CcSEcCtD
Niacin—Abdominal pain—Epirubicin—liver cancer	0.000485	0.001	CcSEcCtD
Niacin—Gastrointestinal pain—Doxorubicin—liver cancer	0.000464	0.000962	CcSEcCtD
Niacin—Hypersensitivity—Epirubicin—liver cancer	0.000452	0.000937	CcSEcCtD
Niacin—Urticaria—Doxorubicin—liver cancer	0.000451	0.000934	CcSEcCtD
Niacin—Abdominal pain—Doxorubicin—liver cancer	0.000448	0.00093	CcSEcCtD
Niacin—Body temperature increased—Doxorubicin—liver cancer	0.000448	0.00093	CcSEcCtD
Niacin—Asthenia—Epirubicin—liver cancer	0.00044	0.000912	CcSEcCtD
Niacin—Pruritus—Epirubicin—liver cancer	0.000434	0.000899	CcSEcCtD
Niacin—Diarrhoea—Epirubicin—liver cancer	0.00042	0.00087	CcSEcCtD
Niacin—Hypersensitivity—Doxorubicin—liver cancer	0.000418	0.000867	CcSEcCtD
Niacin—Asthenia—Doxorubicin—liver cancer	0.000407	0.000844	CcSEcCtD
Niacin—Dizziness—Epirubicin—liver cancer	0.000405	0.000841	CcSEcCtD
Niacin—Pruritus—Doxorubicin—liver cancer	0.000401	0.000832	CcSEcCtD
Niacin—Vomiting—Epirubicin—liver cancer	0.00039	0.000808	CcSEcCtD
Niacin—Diarrhoea—Doxorubicin—liver cancer	0.000388	0.000805	CcSEcCtD
Niacin—Rash—Epirubicin—liver cancer	0.000387	0.000802	CcSEcCtD
Niacin—Dermatitis—Epirubicin—liver cancer	0.000386	0.000801	CcSEcCtD
Niacin—Headache—Epirubicin—liver cancer	0.000384	0.000796	CcSEcCtD
Niacin—Dizziness—Doxorubicin—liver cancer	0.000375	0.000778	CcSEcCtD
Niacin—Nausea—Epirubicin—liver cancer	0.000364	0.000755	CcSEcCtD
Niacin—Vomiting—Doxorubicin—liver cancer	0.000361	0.000748	CcSEcCtD
Niacin—Rash—Doxorubicin—liver cancer	0.000358	0.000742	CcSEcCtD
Niacin—Dermatitis—Doxorubicin—liver cancer	0.000357	0.000741	CcSEcCtD
Niacin—Headache—Doxorubicin—liver cancer	0.000355	0.000737	CcSEcCtD
Niacin—Nausea—Doxorubicin—liver cancer	0.000337	0.000699	CcSEcCtD
Niacin—CYP2D6—Metapathway biotransformation—GPX3—liver cancer	0.000256	0.000504	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PRKCE—liver cancer	0.000255	0.000503	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—H2AFX—liver cancer	0.000255	0.000502	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—IL2—liver cancer	0.000255	0.000502	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—PIK3CB—liver cancer	0.000252	0.000496	CbGpPWpGaD
Niacin—NNMT—Metabolism—PPARG—liver cancer	0.000251	0.000495	CbGpPWpGaD
Niacin—SLC16A1—SLC-mediated transmembrane transport—ALB—liver cancer	0.00025	0.000494	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PSMD10—liver cancer	0.000247	0.000487	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PSMA4—liver cancer	0.000247	0.000487	CbGpPWpGaD
Niacin—QPRT—Metabolism—PIK3CD—liver cancer	0.000246	0.000485	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—RAF1—liver cancer	0.000246	0.000485	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—IL2—liver cancer	0.000244	0.000481	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—HPGDS—liver cancer	0.000244	0.000481	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—CYCS—liver cancer	0.000244	0.00048	CbGpPWpGaD
Niacin—QPRT—Metabolism—ALB—liver cancer	0.000243	0.000479	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TERT—liver cancer	0.000243	0.000479	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—ABL1—liver cancer	0.000243	0.000478	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—IGF2—liver cancer	0.000242	0.000476	CbGpPWpGaD
Niacin—QPRT—Disease—CDKN1B—liver cancer	0.000241	0.000474	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GOT2—liver cancer	0.00024	0.000474	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—PIK3CB—liver cancer	0.00024	0.000474	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000239	0.00047	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—ALB—liver cancer	0.000236	0.000464	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GLUL—liver cancer	0.000232	0.000458	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CPT1B—liver cancer	0.000232	0.000458	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—IL2—liver cancer	0.000231	0.000456	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TERT—liver cancer	0.00023	0.000454	CbGpPWpGaD
Niacin—NNMT—Metabolism—PIK3CD—liver cancer	0.000229	0.000451	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—HGF—liver cancer	0.000228	0.00045	CbGpPWpGaD
Niacin—QPRT—Disease—CTNNB1—liver cancer	0.000227	0.000448	CbGpPWpGaD
Niacin—NNMT—Metabolism—ALB—liver cancer	0.000226	0.000445	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CYP2E1—liver cancer	0.000226	0.000445	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—CSF2—liver cancer	0.000226	0.000445	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—NR1H4—liver cancer	0.000224	0.000442	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—KDR—liver cancer	0.000222	0.000438	CbGpPWpGaD
Niacin—QPRT—Disease—CDKN1A—liver cancer	0.000222	0.000437	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MAPK14—liver cancer	0.000221	0.000435	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—IL2—liver cancer	0.000221	0.000435	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTA3—liver cancer	0.00022	0.000434	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—ESR1—liver cancer	0.000217	0.000427	CbGpPWpGaD
Niacin—SLC22A5—SLC-mediated transmembrane transport—ALB—liver cancer	0.000215	0.000424	CbGpPWpGaD
Niacin—QPRT—Metabolism—PIK3CB—liver cancer	0.000215	0.000423	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—F2—liver cancer	0.000214	0.000422	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—RAF1—liver cancer	0.000213	0.00042	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000212	0.000418	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CYCS—liver cancer	0.000211	0.000417	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—KDR—liver cancer	0.000211	0.000415	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—CYCS—liver cancer	0.00021	0.000413	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MAPK14—liver cancer	0.000209	0.000413	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GGT1—liver cancer	0.000207	0.000409	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GOT1—liver cancer	0.000207	0.000409	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—ESR1—liver cancer	0.000205	0.000405	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—APC—liver cancer	0.000205	0.000404	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CG—liver cancer	0.000205	0.000404	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—F2—liver cancer	0.000203	0.0004	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTA4—liver cancer	0.000201	0.000397	CbGpPWpGaD
Niacin—NNMT—Metabolism—PIK3CB—liver cancer	0.0002	0.000393	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—CYP2E1—liver cancer	0.000199	0.000392	CbGpPWpGaD
Niacin—QPRT—Disease—STAT3—liver cancer	0.000198	0.00039	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTA2—liver cancer	0.000196	0.000387	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—CYP2E1—liver cancer	0.000196	0.000386	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—APC—liver cancer	0.000194	0.000383	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3CG—liver cancer	0.000194	0.000383	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—PPARA—liver cancer	0.000193	0.00038	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—BRAF—liver cancer	0.000192	0.000379	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTA1—liver cancer	0.000189	0.000373	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—VEGFA—liver cancer	0.000188	0.00037	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—NAT2—liver cancer	0.000187	0.000369	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GSTP1—liver cancer	0.000186	0.000367	CbGpPWpGaD
Niacin—QPRT—Disease—MYC—liver cancer	0.000184	0.000363	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—HMOX1—liver cancer	0.000184	0.000362	CbGpPWpGaD
Niacin—QPRT—Disease—TGFB1—liver cancer	0.000184	0.000362	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—MAPK14—liver cancer	0.000183	0.00036	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—GGT1—liver cancer	0.000182	0.00036	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—BRAF—liver cancer	0.000182	0.00036	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000182	0.000359	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CD—liver cancer	0.00018	0.000355	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ALDOB—liver cancer	0.00018	0.000354	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—PIK3CA—liver cancer	0.000178	0.000351	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—SERPINE1—liver cancer	0.000178	0.000351	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—F2—liver cancer	0.000177	0.000349	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—KRAS—liver cancer	0.000176	0.000347	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TGFB1—liver cancer	0.000172	0.000339	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CRABP1—liver cancer	0.000171	0.000338	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GSTM1—liver cancer	0.000171	0.000338	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—PPARA—liver cancer	0.000171	0.000337	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3CD—liver cancer	0.000171	0.000336	CbGpPWpGaD
Niacin—QPRT—Disease—KRAS—liver cancer	0.00017	0.000335	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CG—liver cancer	0.000169	0.000334	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—PIK3CA—liver cancer	0.000169	0.000333	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—SERPINE1—liver cancer	0.000169	0.000333	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—KRAS—liver cancer	0.000167	0.000329	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—GSTP1—liver cancer	0.000164	0.000323	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CYP1A1—liver cancer	0.000162	0.00032	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—PIK3CA—liver cancer	0.000162	0.000319	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—GSTP1—liver cancer	0.000162	0.000319	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—RAF1—liver cancer	0.000161	0.000317	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—KRAS—liver cancer	0.000159	0.000314	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CB—liver cancer	0.000157	0.000309	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MTOR—liver cancer	0.000157	0.000309	CbGpPWpGaD
Niacin—QPRT—Disease—PIK3CA—liver cancer	0.000156	0.000308	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—PIK3CA—liver cancer	0.000153	0.000302	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—RAF1—liver cancer	0.000152	0.0003	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—MTHFR—liver cancer	0.000151	0.000298	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—GSTM1—liver cancer	0.000151	0.000297	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—HRAS—liver cancer	0.00015	0.000295	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—HPGDS—liver cancer	0.00015	0.000295	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CD—liver cancer	0.000149	0.000293	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MTOR—liver cancer	0.000149	0.000293	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3CB—liver cancer	0.000149	0.000293	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—GSTM1—liver cancer	0.000149	0.000293	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PPARA—liver cancer	0.000148	0.000293	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—SERPINE1—liver cancer	0.000147	0.00029	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—PPARA—liver cancer	0.000147	0.00029	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CDKN1B—liver cancer	0.000147	0.00029	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—ALB—liver cancer	0.000147	0.00029	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—PIK3CA—liver cancer	0.000147	0.000289	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—AKT1—liver cancer	0.000146	0.000287	CbGpPWpGaD
Niacin—QPRT—Disease—HRAS—liver cancer	0.000145	0.000285	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CASP3—liver cancer	0.000144	0.000284	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IL2—liver cancer	0.000144	0.000284	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—IL6—liver cancer	0.000143	0.000283	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—ALB—liver cancer	0.000143	0.000282	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—CYP1A1—liver cancer	0.000143	0.000281	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—HRAS—liver cancer	0.000142	0.00028	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TP53—liver cancer	0.000142	0.000279	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—CYP1A1—liver cancer	0.000141	0.000278	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CCND1—liver cancer	0.00014	0.000277	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—JUN—liver cancer	0.00014	0.000276	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CDKN1B—liver cancer	0.00014	0.000275	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CTNNB1—liver cancer	0.000139	0.000274	CbGpPWpGaD
Niacin—QPRT—Disease—IL6—liver cancer	0.000138	0.000273	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—AKT1—liver cancer	0.000138	0.000272	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CASP3—liver cancer	0.000137	0.00027	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IL2—liver cancer	0.000137	0.000269	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MMP9—liver cancer	0.000136	0.000269	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—IL6—liver cancer	0.000136	0.000268	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CDKN1A—liver cancer	0.000136	0.000268	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—HRAS—liver cancer	0.000136	0.000267	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PSMD10—liver cancer	0.000133	0.000263	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PSMA4—liver cancer	0.000133	0.000263	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CCND1—liver cancer	0.000133	0.000262	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—RAF1—liver cancer	0.000133	0.000262	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—JUN—liver cancer	0.000133	0.000262	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MAPK8—liver cancer	0.000133	0.000261	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—AKT1—liver cancer	0.000132	0.000261	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CTNNB1—liver cancer	0.000132	0.00026	CbGpPWpGaD
Niacin—QPRT—Metabolism—PIK3CA—liver cancer	0.000131	0.000258	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GOT2—liver cancer	0.00013	0.000256	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CB—liver cancer	0.00013	0.000256	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—RAF1—liver cancer	0.00013	0.000255	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MMP9—liver cancer	0.000129	0.000255	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CDKN1A—liver cancer	0.000129	0.000254	CbGpPWpGaD
Niacin—QPRT—Disease—AKT1—liver cancer	0.000128	0.000252	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—ALB—liver cancer	0.000127	0.000251	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CG—liver cancer	0.000127	0.000251	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MAPK8—liver cancer	0.000126	0.000248	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—AKT1—liver cancer	0.000125	0.000247	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PPARG—liver cancer	0.000123	0.000242	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—VEGFA—liver cancer	0.000122	0.000241	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP2E1—liver cancer	0.000122	0.000241	CbGpPWpGaD
Niacin—NNMT—Metabolism—PIK3CA—liver cancer	0.000122	0.00024	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—STAT3—liver cancer	0.000121	0.000239	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—AKT1—liver cancer	0.00012	0.000236	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—IL2—liver cancer	0.000119	0.000235	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—VEGFA—liver cancer	0.000116	0.000229	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—RAF1—liver cancer	0.000115	0.000227	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—STAT3—liver cancer	0.000115	0.000227	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYCS—liver cancer	0.000114	0.000225	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MYC—liver cancer	0.000113	0.000222	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TGFB1—liver cancer	0.000112	0.000221	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GGT1—liver cancer	0.000112	0.000221	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GOT1—liver cancer	0.000112	0.000221	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CD—liver cancer	0.000112	0.00022	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ALB—liver cancer	0.00011	0.000218	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—ALB—liver cancer	0.000109	0.000216	CbGpPWpGaD
Niacin—QPRT—Metabolism—AKT1—liver cancer	0.000107	0.000211	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—UGDH—liver cancer	0.000107	0.000211	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MYC—liver cancer	0.000107	0.00021	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TGFB1—liver cancer	0.000107	0.00021	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—KRAS—liver cancer	0.000104	0.000205	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—VEGFA—liver cancer	0.000101	0.0002	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTP1—liver cancer	0.000101	0.000198	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—EPT1—liver cancer	0.0001	0.000198	CbGpPWpGaD
Niacin—NNMT—Metabolism—AKT1—liver cancer	9.94e-05	0.000196	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—HMOX1—liver cancer	9.93e-05	0.000196	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—RAF1—liver cancer	9.9e-05	0.000195	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—KRAS—liver cancer	9.87e-05	0.000194	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CB—liver cancer	9.74e-05	0.000192	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CA—liver cancer	9.56e-05	0.000188	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—TAT—liver cancer	9.52e-05	0.000188	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TGFB1—liver cancer	9.3e-05	0.000183	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TP53—liver cancer	9.25e-05	0.000182	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTM1—liver cancer	9.25e-05	0.000182	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3CA—liver cancer	9.07e-05	0.000179	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—HRAS—liver cancer	8.85e-05	0.000174	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TP53—liver cancer	8.77e-05	0.000173	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP1A1—liver cancer	8.77e-05	0.000173	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—KRAS—liver cancer	8.61e-05	0.00017	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IL6—liver cancer	8.47e-05	0.000167	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—HRAS—liver cancer	8.39e-05	0.000165	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—MTHFR—liver cancer	8.17e-05	0.000161	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IL6—liver cancer	8.03e-05	0.000158	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PPARA—liver cancer	8.02e-05	0.000158	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CA—liver cancer	7.91e-05	0.000156	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—AKT1—liver cancer	7.81e-05	0.000154	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TP53—liver cancer	7.65e-05	0.000151	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—AKT1—liver cancer	7.41e-05	0.000146	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—HRAS—liver cancer	7.32e-05	0.000144	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CG—liver cancer	6.87e-05	0.000135	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PPARG—liver cancer	6.63e-05	0.000131	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CPT1B—liver cancer	6.47e-05	0.000128	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GLUL—liver cancer	6.47e-05	0.000128	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—AKT1—liver cancer	6.46e-05	0.000127	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NR1H4—liver cancer	6.24e-05	0.000123	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTA3—liver cancer	6.13e-05	0.000121	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CD—liver cancer	6.04e-05	0.000119	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ALB—liver cancer	5.96e-05	0.000117	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CA—liver cancer	5.94e-05	0.000117	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTA4—liver cancer	5.61e-05	0.000111	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTA2—liver cancer	5.47e-05	0.000108	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTA1—liver cancer	5.28e-05	0.000104	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CB—liver cancer	5.26e-05	0.000104	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NAT2—liver cancer	5.22e-05	0.000103	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ALDOB—liver cancer	5e-05	9.86e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—AKT1—liver cancer	4.85e-05	9.56e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CRABP1—liver cancer	4.77e-05	9.4e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HPGDS—liver cancer	4.17e-05	8.22e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PSMD10—liver cancer	3.72e-05	7.33e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PSMA4—liver cancer	3.72e-05	7.33e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GOT2—liver cancer	3.62e-05	7.13e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP2E1—liver cancer	3.4e-05	6.7e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CA—liver cancer	3.21e-05	6.32e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYCS—liver cancer	3.18e-05	6.27e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GGT1—liver cancer	3.12e-05	6.15e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GOT1—liver cancer	3.12e-05	6.15e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTP1—liver cancer	2.8e-05	5.53e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HMOX1—liver cancer	2.76e-05	5.45e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—AKT1—liver cancer	2.62e-05	5.16e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTM1—liver cancer	2.58e-05	5.08e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP1A1—liver cancer	2.44e-05	4.81e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—MTHFR—liver cancer	2.28e-05	4.49e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PPARA—liver cancer	2.23e-05	4.4e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CG—liver cancer	1.91e-05	3.77e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PPARG—liver cancer	1.85e-05	3.64e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CD—liver cancer	1.68e-05	3.31e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ALB—liver cancer	1.66e-05	3.27e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CB—liver cancer	1.47e-05	2.89e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CA—liver cancer	8.94e-06	1.76e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—AKT1—liver cancer	7.3e-06	1.44e-05	CbGpPWpGaD
